Cargando…
547. Molnupiravir and Nirmatrelvir/Ritonavir Effectiveness in Reducing the Risk for COVID-19 Disease Progression and Death
BACKGROUND: Molnupiravir (M) and Nirmatrelvir/Ritonavir (N/R) have been authorized for use in COVID-19 patients at high risk for severe disease. We aimed to evaluate the effectiveness of M and N/R in highly vulnerable SARS-CoV-2 patients using a retrospective cohort study design. METHODS: The study...
Autores principales: | Paraskevis, Dimitrios, Gkova, Mary, Mellou, Kassiani, Gkolfinopoulou, Kassiani, Kostaki, Evangelia Georgia, Loukides, Stylianos, Kotanidou, Anastasia, Skoutelis, Athanasios, Thiraios, Eleftherios, Saroglou, George, Zografopoulos, Dimitrios, Mossialos, Elias, Zaoutis, Theoklis, Gaga, Mina, Antoniadou, Anastasia, Tsiodras, Sotirios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677556/ http://dx.doi.org/10.1093/ofid/ofad500.616 |
Ejemplares similares
-
Time Lag between COVID-19 Diagnosis and Symptoms Onset for Different Population Groups: Evidence That Self-Testing in Schools Was Associated with Timely Diagnosis among Children
por: Mellou, Kassiani, et al.
Publicado: (2022) -
2488. Healthcare-associated infections in acute care hospitals in Greece, results of the third Point Prevalence Survey, April – December 2022
por: Palaiopanos, Konstantinos, et al.
Publicado: (2023) -
1892. Rise of COVID-19 Re-infections as Omicron Variant Prevailed: Implications on Monitoring the Course of the Pandemic
por: Mellou, Kassiani, et al.
Publicado: (2022) -
Influenza transmission during COVID-19 measures downscaling in Greece, August 2022: evidence for the need of continuous integrated surveillance of respiratory viruses
por: Mellou, Kassiani, et al.
Publicado: (2023) -
A COVID-19 outbreak among migrants in a hosting facility in Greece, April
2020
por: Mellou, Kassiani, et al.
Publicado: (2022)